Clinical Lipidology

• Twenty-five Years of Statins: Where Do We Go From Here? After more than 25 years in clinical use, statins have transformed the field of lipid management and cardiovascular risk reduction. What now?
  Clinical Lipidology, April 10, 2015
• Are Add-on to Statins Needed in Hypercholesterolemia? Does combining a statin with a bile acid sequestrant, fibrate or ezetimibe reduce LDL-C and improve glycemic control in patients with diabetes?
  Clinical Lipidology, January 16, 2015
• Diet and Lifestyle Interventions on Lipids How will personalized medicine add to non-pharmacologic prevention measures aimed at improving lipid levels?
  Clinical Lipidology, November 17, 2014
• Role of Nutrition and Nutritional Supplements in Dyslipidemia What should you recommend for patients with dyslipidemia -- who don't want to take statins?
  Clinical Lipidology, September 10, 2014
• Novel Anti-obesity Drugs and Plasma Lipids Can 'one pill make you smaller' yet?
  Clinical Lipidology, August 08, 2014
• Recalcitrant Hypercholesterolemia With Best Standard of Care Find out what to do when guideline based therapy isn't hitting the mark for cholesterol reduction.
  Clinical Lipidology, July 10, 2014
• Adipose Tissue, Inflammation and Atherosclerosis Extensive research in recent decades has revealed manifold metabolic functions of adipose tissue, beyond its purpose as a simple storage organ for fatty acids.
  Clinical Lipidology, April 10, 2014
• Treatment of Homozygous Familial Hypercholesterolemia Find out more about this relatively rare disease with reduced receptor-mediated catabolism of LDL causing high plasma LDL cholesterol and premature coronary artery disease.
  Clinical Lipidology, March 10, 2014
• Is Irisin an Early Marker of Statin-Induced Myopathy? Learn more about the ties that bind irisin and statin-induced myopathy.
  Clinical Lipidology, February 10, 2014
• Fenofibrate and Renal Disease Find out more about the potentially cardioprotective effects of fenofibrate for patients with type 2 diabetes.
  Clinical Lipidology, January 10, 2014
• Lipoprotein Apheresis for Familial Hypercholesterolemia Apheresis may be the answer for patients with hypercholesterolemia who are statin refractory.
  Clinical Lipidology, December 11, 2013
• Linoleic Acid Protection Against Death From CV Disease Is there a link between dietary linoleic acid intake and death from cardiovascular disease?
  Clinical Lipidology, November 11, 2013
• Pediatric Lipid Screening Primordial and primary prevention of premature cardiovascular disease has become an important focus of preventive healthcare in the pediatric population.
  Clinical Lipidology, October 11, 2013
• Homozygous Familial Hypercholesterolemia Homozygous familial hypercholesterolemia is a rare but significant cause of early-onset coronary heart disease. Do you know the signs?
  Clinical Lipidology, September 12, 2013
• Reduction of Cholesterol by Alternative Therapies What's the clinical evidence regarding functional foods, herbal products and medicinal plants for improving plasma cholesterol, triglycerides and glucose levels?
  Clinical Lipidology, August 12, 2013
• Oxysterol Consumption and Heart Disease In this interview Fred Kummerow expounds on his hypothesis regarding the origins of heart disease.
  Clinical Lipidology, July 11, 2013
• Marine n-3 Polyunsaturated Fatty Acids Can fish oil help to prevent falls in the elderly?
  Clinical Lipidology, June 11, 2013
• Microalbuminuria in Patients Receiving Statins Learn about the link between statins and kidneys.
  Clinical Lipidology, May 10, 2013
• Non-HDL Cholesterol in Coronary Heart Disease Non-HDL cholesterol biomarkers provide clinically useful information -- both in coronary risk prediction and in lipid management decision-making.
  Clinical Lipidology, April 11, 2013
• Risk Factors for Cardiovascular Disease What flips the switch to turn triglycerides from a major source of dietary energy into a major metabolic enemy?
  Clinical Lipidology, March 11, 2013